| Q33808035 | Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter. |
| Q37672037 | HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum. |
| Q34713944 | High-resolution genetic mapping in the diversity outbred mouse population identifies Apobec1 as a candidate gene for atherosclerosis |
| Q37671995 | Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects. |
| Q35450098 | Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter |
| Q37501478 | Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport |
| Q64054571 | Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport |
| Q34458860 | Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport. |
| Q34553522 | Responsiveness of cardiometabolic-related microbiota to diet is influenced by host genetics. |
| Q36960223 | Role of Histidine 547 of Human Dopamine Transporter in Molecular Interaction with HIV-1 Tat and Dopamine Uptake |